Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M202Revenue (TTM) $M31.8Net Margin (%)122Altman Z-Score-0.8
Enterprise Value $M91.5EPS (TTM) $2.4Operating Margin %-163.7Piotroski F-Score4
P/E(ttm)3.5Beneish M-Score1.1Pre-tax Margin (%)-181.3Higher ROA y-yY
Price/Book1.210-y EBITDA Growth Rate %--Quick Ratio7.4Cash flow > EarningsN
Price/Sales5.75-y EBITDA Growth Rate %--Current Ratio7.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-205.3ROA % (ttm)14.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)28.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.8ROIC % (ttm)-82.8Gross Margin Increase y-yN

Gurus Latest Trades with ZGNX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ZGNX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ZGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-41.41view
HAWLEY ROGERDirector 2015-12-15Buy10,000$13.74-41.41view
TANNENBAUM RENEE PDirector 2015-12-03Buy5,000$15.4-47.73view
HAWLEY ROGERDirector 2015-06-16Buy6,250$12.72-36.71view
HAWLEY ROGERCEO 2015-03-16Buy17,500$10.48-23.19view
GARNER CAM LDirector 2014-06-13Buy3,750$13.28-39.38view
Shively Richard ScottChief Commercial Officer 2014-06-03Sell2,404$16.8-52.08view
RHOADS ANN DEVP, CFO, Treasurer & Sec. 2014-06-03Sell2,404$16.8-52.08view
HAWLEY ROGERCEO 2014-06-03Sell3,135$16.8-52.08view
FARR STEPHEN JPresident and COO 2014-06-03Sell2,613$16.8-52.08view

Quarterly/Annual Reports about ZGNX:

News about ZGNX:

Articles On GuruFocus.com
Analysts Weigh in on Zogenix in Light of Selling Zohydro Mar 12 2015 
Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB Dec 24 2012 
(ZGNX) CEO Roger Hawley buys 10,000 Shares Dec 06 2010 

More From Other Websites
Zogenix Announces Agreement to Refinance Debt, Further Increasing Company’s Expected 2017 Cash... Jun 21 2016
Zogenix Announces Agreement to Refinance Debt, Further Increasing Company’s Expected 2017 Cash... Jun 21 2016
ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Jun 21 2016
Zogenix Announces Initiation of Multi-National Phase 3 Clinical Trial for ZX008 in Dravet Syndrome Jun 07 2016
ZOGENIX, INC. Files SEC form 8-K, Other Events Jun 07 2016
Zogenix Announces Initiation of Multi-National Phase 3 Clinical Trial for ZX008 in Dravet Syndrome Jun 07 2016
Zogenix to Participate in Jefferies 2016 Healthcare Conference May 31 2016
Zogenix to Participate in Jefferies 2016 Healthcare Conference May 31 2016
ETF’s with exposure to Zogenix, Inc. : May 24, 2016 May 24 2016
Zogenix, Inc. :ZGNX-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 May 23 2016
ZOGENIX, INC. Financials May 19 2016
Zogenix reports 1Q loss May 10 2016
Zogenix reports 1Q loss May 10 2016
ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 10 2016
Zogenix Provides Corporate Update and Reports First Quarter 2016 Financial Results May 10 2016
Zogenix Provides Corporate Update and Reports First Quarter 2016 Financial Results May 10 2016
Q1 2016 Zogenix Inc Earnings Release - After Market Close May 10 2016
ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement May 05 2016
Zogenix Announces New Efficacy and Safety Data on ZX008 for Treatment of Seizures in Dravet Syndrome May 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)